Controloc Control
pantoprazole
Table of contents
Overview
This is a summary of the European public assessment report (EPAR) for Controloc Control. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Controloc Control.
This EPAR was last updated on 29/10/2019
Authorisation details
Product details | |
---|---|
Name |
Controloc Control
|
Agency product number |
EMEA/H/C/001097
|
Active substance |
pantoprazole
|
International non-proprietary name (INN) or common name |
pantoprazole
|
Therapeutic area (MeSH) |
Gastroesophageal Reflux
|
Anatomical therapeutic chemical (ATC) code |
A02BC02
|
Publication details | |
---|---|
Marketing-authorisation holder |
Takeda GmbH
|
Revision |
12
|
Date of issue of marketing authorisation valid throughout the European Union |
11/06/2009
|
Contact address |
Product information
22/08/2019 Controloc Control - EMEA/H/C/001097 - IG/1120
Contents
- Annex I - Summary of product characteristics
- Annex IIA - Manufacturing-authorisation holder responsible for batch release
- Annex IIB - Conditions of the marketing authorisation
- Annex IIIA - Labelling
- Annex IIIB - Package leaflet
Please note that the size of the above document can exceed 50 pages.
You are therefore advised to be selective about which sections or pages you wish to print.
Pharmacotherapeutic group
Pharmacotherapeutic group
Proton pump inhibitors
Therapeutic indication
Therapeutic indication
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.